November 25, 2024

Rangers activate Corey Seager from 10-day injured list, place INF/OF Brad Miller on 10-day injured list

Corey Seager #CoreySeager

Arlington, Texas — The Texas Rangers today announced the following additional roster moves ahead of Wednesday night’s game against the Chicago White Sox at Globe Life Field:

Seager, 29, has batted .350/.413/.631/1.044 (92-263) with 15 home runs, 29 doubles, and 58 RBI across 66 games with Texas this season, ranking among American League leaders (min. 250 PA) in batting average (1st), on-base pct. (1st), slugging pct. (2nd), OPS (2nd), and doubles (T3rd). He was on the Injured List from July 22-Aug. 1 with a right thumb sprain, an injury suffered while sliding into second base in the eighth inning of his most recent appearance on July 21 vs. Los Angeles-NL. This was his second Injured List stint of the 2023 campaign, as he also spent April 12-May 16 on the 10-day Injured List with a left hamstring strain.

Prior to being placed on the Injured List, Seager batted .365/.414/.714/1.129 (23-63) with 5 home runs, 7 doubles, and 10 RBI over 16 contests in July. He started at shortstop for the American League in the 2023 Major League Baseball All-Star Game on July 11 in Seattle, becoming the third shortstop in Rangers history to start the Mid-Summer Classic along with Álex Rodríguez (2001-02-03) and Toby Harrah (1976).

Miller, 33, has batted .214 (12-56) with one home run and 6 RBI in 27 games with the Rangers this season. He missed 27 games after spending May 31-June 29 on the 10-day Injured List with a right oblique strain. His 13 starts at designated hitter in 2023 are third-most among Texas batters to Robbie Grossman (25 starts) and Ezequiel Duran (19 starts). The first date that Miller will be eligible to be reinstated from the Injured List is August 11.

Following today’s transactions, the Rangers remain at the 40-man limit on the club’s Major League roster, along with three players (Jacob deGrom, Brett Martin, and Jake Odorizzi) on the 60-day Injured List.

Leave a Reply